By-health Co., Ltd. (300146) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

By-health Co., Ltd.

Why is By-health Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 1.23% and Operating profit at 34.47% over the last 5 years

The company has declared Negative results for the last 6 consecutive quarters

INTEREST(HY) At CNY 8.41 MM has Grown at 129.98%
OPERATING CASH FLOW(Y) Lowest at CNY 1,146.56 MM
NET PROFIT(9M) At CNY 498.19 MM has Grown at -23.39%

With ROE of 4.51%, it has a fair valuation with a 1.18 Price to Book Value

Over the past year, while the stock has generated a return of -7.92%, its profits have fallen by -49.8%
At the current price, the company has a high dividend yield of 4.6

Below par performance in long term as well as near term

Along with generating -7.92% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to By-health Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is By-health Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

By-health Co., Ltd.

-7.19%

-0.56

24.20%

China Shanghai Composite

14.77%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

1.23%

EBIT Growth (5y)

34.47%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.40

Sales to Capital Employed (avg)

0.66

Tax Ratio

29.36%

Dividend Payout Ratio

92.88%

Pledged Shares

Institutional Holding

0.02%

ROCE (avg)

21.48%

ROE (avg)

14.00%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.18

EV to EBIT

13.05

EV to EBITDA

9.10

EV to Capital Employed

1.31

EV to Sales

1.46

PEG Ratio

Dividend Yield

4.64%

ROCE (Latest)

10.06%

ROE (Latest)

4.51%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

PRE-TAX PROFIT(Q)

At CNY 371.56 MM has Grown at 120.36%

RAW MATERIAL COST(Y)

Fallen by -1.42% (YoY

CASH AND EQV(HY)

Highest at CNY 11,317.7 MM

NET PROFIT(Q)

At CNY 260.15 MM has Grown at 87.32%

-26What is not working for the Company

INTEREST(HY)

At CNY 8.41 MM has Grown at 129.98%

OPERATING CASH FLOW(Y)

Lowest at CNY 1,146.56 MM

NET PROFIT(9M)

At CNY 498.19 MM has Grown at -23.39%

ROCE(HY)

Lowest at 4.43%

DEBT-EQUITY RATIO (HY)

Highest at -43.28 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 9.29%

NET SALES(Q)

Fallen at -11.62%

Here's what is working for By-health Co., Ltd.

Pre-Tax Profit

At CNY 371.56 MM has Grown at 120.36%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 260.15 MM has Grown at 87.32%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Cash and Eqv

Highest at CNY 11,317.7 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by -1.42% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for By-health Co., Ltd.

Interest

At CNY 8.41 MM has Grown at 129.98%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow

Lowest at CNY 1,146.56 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

Fallen at -11.62%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Debt-Equity Ratio

Highest at -43.28 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 9.29%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio